Projection of the future diabetes burden in the United States through 2060

Ji Lin, Theodore J Thompson, Yiling J Cheng, Xiaohui Zhuo, Ping Zhang, Edward Gregg, Deborah B Rolka, Ji Lin, Theodore J Thompson, Yiling J Cheng, Xiaohui Zhuo, Ping Zhang, Edward Gregg, Deborah B Rolka

Abstract

Background: In the United States, diabetes has increased rapidly, exceeding prior predictions. Projections of the future diabetes burden need to reflect changes in incidence, mortality, and demographics. We applied the most recent data available to develop an updated projection through 2060.

Methods: A dynamic Markov model was used to project prevalence of diagnosed diabetes among US adults by age, sex, and race (white, black, other). Incidence and current prevalence were from the National Health Interview Survey (NHIS) 1985-2014. Relative mortality was from NHIS 2000-2011 follow-up data linked to the National Death Index. Future population estimates including birth, death, and migration were from the 2014 Census projection.

Results: The projected number and percent of adults with diagnosed diabetes would increase from 22.3 million (9.1%) in 2014 to 39.7 million (13.9%) in 2030, and to 60.6 million (17.9%) in 2060. The number of people with diabetes aged 65 years or older would increase from 9.2 million in 2014 to 21.0 million in 2030, and to 35.2 million in 2060. The percent prevalence would increase in all race-sex groups, with black women and men continuing to have the highest diabetes percent prevalence, and black women and women of other race having the largest relative increases.

Conclusions: By 2060, the number of US adults with diagnosed diabetes is projected to nearly triple, and the percent prevalence double. Our estimates are essential to predict health services needs and plan public health programs aimed to reduce the future burden of diabetes.

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Competing interests

The author’s declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Projection of diagnosed diabetes prevalence in US adults: a overall number, b overall percent, c number by race and sex, d percent by race and sex, e number by age and year, f and percent by age and year

References

    1. Long-term Trends in Diabetes, [article online], Available from .
    1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431. doi: 10.2337/diacare.21.9.1414.
    1. Boyle JP, Honeycutt AA, Narayan KV, Hoerger TJ, Geiss LS, Chen H, Thompson TJ. Projection of diabetes burden through 2050 impact of changing demography and disease prevalence in the US. Diabetes Care. 2001;24:1936–1940. doi: 10.2337/diacare.24.11.1936.
    1. Narayan KV, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden US, 2005–2050. Diabetes Care. 2006;29:2114–2116. doi: 10.2337/dc06-1136.
    1. Honeycutt AA, Boyle JP, Broglio KR, Thompson TJ, Hoerger TJ, Geiss LS, Narayan KV. A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health care management science. 2003;6:155–164. doi: 10.1023/A:1024467522972.
    1. Imperatore G, Boyle JP, Thompson TJ, Case D, Dabelea D, Hamman RF, Lawrence JM, Liese AD, Liu LL, Mayer-Davis EJ. Projections of type 1 and type 2 diabetes burden in the US population aged< 20 years through 2050 dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35:2515–2520. doi: 10.2337/dc12-0669.
    1. Geiss LS, Wang J, Cheng Y, Thompson TJ, Barker L, Li Y, Albright AL, Gregg EW. Prevalence and incidence trends for diagnosed diabetes among adults aged 20–79 years, United States, 1980–2012. J Am Med Assoc. 2014;312:1218–1226. doi: 10.1001/jama.2014.11494.
    1. Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, Barker L. Trends in death rates among US adults with and without diabetes between 1997 and 2006 findings from the National Health Interview Survey. Diabetes Care. 2012;35:1252–1257. doi: 10.2337/dc11-1162.
    1. Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KV, Thompson TJ. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: a modelling study. The Lancet Diabetes & Endocrinology. 2014;2:867–874. doi: 10.1016/S2213-8587(14)70161-5.
    1. Arterburn DE, Bogart A, Sherwood NE, Sidney S, Coleman KJ, Haneuse S, O’Connor PJ, Theis MK, Campos GM, McCulloch D. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013;23:93–102. doi: 10.1007/s11695-012-0802-1.
    1. National Health Interview Survey: Methods. [article online], 2016. Available from .
    1. Cheng YJ, Gregg EW, Rolka DB, Thompson TJ. Using multi-year national survey cohorts for period estimates: an application of weighted discrete Poisson regression for assessing annual national mortality in US adults with and without diabetes, 2000–2006. Popul Health Metrics. 2016;14:48. doi: 10.1186/s12963-016-0117-x.
    1. American Diabetes Association Economic costs of diabetes in the US in 2012. Diabetes Care. 2013;36:1033–1046. doi: 10.2337/dc12-2625.
    1. Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the community preventive services task ForceCombined diet and physical activity promotion programs to prevent diabetes. Ann Intern Med. 2015;163:437–451. doi: 10.7326/M15-0452.
    1. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S. Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438–1447. doi: 10.1016/S0140-6736(11)60393-0.
    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. doi: 10.2337/diacare.27.5.1047.
    1. Huang ES, Basu A, O'Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the US. Diabetes Care. 2009;32:2225–2229. doi: 10.2337/dc09-0459.
    1. U.S. CENSUS Bureau (Ed.). 2012 to 2060 Population Projections based on Census 2010. United States Census Bureau, 2012.
    1. U.S. CENSUS Bureau (Ed.). 2004 Interim National Population Projections United States Census Bureau, 2004.
    1. Vincent GK, Velkoff VA. The next four decades: the older population in the United States: 2010 to 2050. Economics and Statistics Administration, US Census Bureau: US Department of Commerce; 2010.
    1. Diabetes Prevention Program Research Group The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012;35:723–730. doi: 10.2337/dc11-1468.
    1. Li R, Qu S, Zhang P, Chattopadhyay S, Gregg EW, Albright A, Hopkins D, Pronk NP. Economic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the community preventive services task force. Ann Intern Med. 2015;163:452–460. doi: 10.7326/M15-0469.
    1. Centers for Disease Control and Prevention (Ed.). National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta: U.S. Department of Health and Human Services. p. 2014.
    1. Brinks R, Bardenheier BH, Hoyer A, Lin J, Landwehr S, Gregg EW. Development and demonstration of a state model for the estimation of incidence of partly undetected chronic diseases. BMC Med Res Methodol. 2015;15:98. doi: 10.1186/s12874-015-0094-y.
    1. Mainous AG, Baker R, Koopman RJ, Saxena S, Diaz VA, Everett CJ, Majeed A. Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way. Diabetologia. 2007;50:934–940. doi: 10.1007/s00125-006-0528-5.
    1. Cunningham SA, Riosmena F, Wang J, Boyle JP, Rolka DB, Geiss LS. Decreases in diabetes-free life expectancy in the US and the role of obesity. Diabetes Care. 2011;34:2225–2230. doi: 10.2337/dc11-0462.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa